Primary care physicians hold unprecedented influence over ADHD outcomes in children, yet many miss critical diagnostic windows when intervention proves most effective. This reality affects millions of families navigating a disorder that extends far beyond simple attention problems into complex neurobiological territory. The latest clinical synthesis reveals ADHD as a multifactorial neurodevelopmental condition rooted in genetic predisposition and specific alterations within cortico-subcortical brain circuits. These circuits rely heavily on dopaminergic and noradrenergic neurotransmitter systems for proper executive function. The disorder's clinical presentation shifts dramatically with age and environmental context, often masked by comorbid conditions including learning disabilities, anxiety disorders, and depression. Diagnosis remains entirely clinical, requiring standardized criteria applied across multiple settings while systematically excluding conditions that mimic ADHD symptoms. This diagnostic complexity places enormous responsibility on pediatricians as the primary gatekeepers for recognition and referral. Treatment effectiveness depends on multimodal approaches combining psychosocial interventions, educational accommodations, and targeted pharmacological therapy when clinically indicated. The evidence strongly supports early identification and intervention, with pediatricians serving as central coordinators between families, schools, and specialized healthcare teams. However, this coordination role demands sophisticated understanding of neurobiological mechanisms and treatment protocols that extend beyond traditional pediatric training. The findings underscore a critical gap between ADHD's complex pathophysiology and the practical diagnostic tools available in primary care settings, suggesting that improved pediatric education and systematic screening protocols could dramatically improve long-term outcomes for affected children.